L. Shi et al.
N-[(4-Chlorophenylthio)(4-fluorophenyl)methyl]benza-
mide (4b, C20H15ClFNOS)
N-[(4-Chlorophenylthio)(2-naphthalenyl)methyl]benza-
mide (4f, C24H18ClNOS)
White solid; m.p.: 186–189 °C; 91 % ee determined by
HPLC analysis (chiralpak OD-H, hexane/i-PrOH = 90:10,
1.0 cm3/min, 228 nm), tminor = 8.7 min, tmajor = 14.4 min;
1H NMR (400 MHz, CDCl3): d = 7.65 (d, J = 7.6 Hz, 2H),
7.53–7.36 (m, 7H), 7.26–7.20 (m, 2H), 7.08–7.04 (m, 2H),
6.73–6.66 (m, 2H) ppm; 13C NMR (100 MHz, CDCl3): d =
166.3, 163.8, 116.4, 134.5, 134.3, 134.2, 133.8, 133.5,
132.0, 131.2, 129.3, 128.7, 128.5, 128.4, 126.9, 115.9,
115.7, 59.2 ppm; ESI–MS: m/z = 394.8 ([M?Na]?); IR
(KBr): m = 3306, 2970, 1525, 1490, 1150, 801, 747, 514,
White solid; m.p.: 190–193 °C; 83 % ee determined by
HPLC analysis (chiralpak OD-H, hexane/i-PrOH = 90:10,
1.0 cm3/min, 228 nm), tminor = 22.1 min, tmajor = 27.0 min;
1H NMR (400 MHz, CDCl3): d = 7.87–7.70 (m, 4H), 7.67–
7.60 (m, 2H), 7.54–7.50 (m, 1H), 7.45–7.41 (m, 7H), 7.26–
7.22 (m, 2H), 6.90 (d, J = 9.2 Hz, 1H), 6.79 (d, J = 9.2 Hz,
1H) ppm; 13C NMR (100 MHz, CDCl3): d = 166.3, 135.6,
134.4, 133.9, 133.7, 133.2, 133.1, 132.0, 131.4, 129.3,
128.9, 128.7, 128.1, 127.7, 126.9, 126.6, 125.5, 124.5,
60.1 ppm; ESI–MS: m/z = 426.1 ([M?Na]?); IR (KBr): m
= 3310, 3049, 3001, 1669, 1561, 1384, 840, 743, 615,
494, 396 cm-1
.
471 cm-1
.
N-[(4-Chlorophenylthio)(3-chlorophenyl)methyl]benza-
mide (4c, C20H15Cl2NOS)
N-[(4-Chlorophenylthio)(m-tolyl)methyl]benzamide
(4g, C21H18ClNOS)
White solid; m.p.: 165–167 °C; 89 % ee determined by
HPLC analysis (chiralpak OD-H, hexane/i-PrOH =
White solid; m.p.: 173–176 °C; 81 % ee determined by
HPLC analysis (chiralpak OD-H, hexane/i-PrOH = 90:10,
1.0 cm3/min, 228 nm), tminor = 7.5 min, tmajor = 14.2 min;
1H NMR (400 MHz, CDCl3): d = 7.65 (d, J = 7.6 Hz, 2H),
7.50–7.48 (m, 1H), 7.41–7.37 (m, 4H), 7.27–7.21 (m, 5H),
7.13 (d, J = 6.4 Hz, 1H), 6.76–6.70 (m, 2H), 2.35 (s, 3H)
ppm; 13C NMR (100 MHz, CDCl3): d = 166.2, 138.7,
138.2, 134.0, 133.6, 131.8, 129.2, 128.8, 128.6, 127.3,
126.9, 123.6, 21.5 ppm; ESI–MS: m/z = 390.1 ([M?Na]?);
IR (KBr): m = 3309, 3079, 3050, 3022, 1680, 1575, 1492,
1027, 801, 728, 693, 465 cm-1; HRMS (ESI): m/z calcd for
C21H18ClNOS ([M?Na]?) 390.0690, found 390.0681.
90:10, 1.0 cm3/min, 228 nm), tminor = 9.0 min, tmajor
=
1
15.0 min; H NMR (400 MHz, CDCl3): d = 7.66 (d, J =
7.2 Hz, 2H), 7.65–7.50 (m, 2H), 7.249–7.29 (m, 5H),
7.26–7.20 (m, 4H), 6.73–6.68 (m, 2H) ppm; 13C NMR
(100 MHz, CDCl3): d = 166.3, 140.3, 134.8, 134.6,
133.9, 133.3, 132.1, 130.9, 130.1, 126.9, 126.8, 124.9,
59.3 ppm; ESI–MS: m/z = 410.0 ([M?Na]?); IR (KBr):
m = 3326, 3063, 1668, 1601, 1573, 1432, 1303, 1094,
824, 759 cm-1
.
N-[(4-Chlorophenylthio)(4-chlorophenyl)methyl]benza-
mide (4d, C20H15Cl2NOS)
White solid; m.p.: 195–197 °C; 88 % ee determined by
HPLC analysis (chiralpak OD-H, hexane/i-PrOH = 90:10,
1.0 cm3/min, 228 nm), tminor = 9.6 min, tmajor = 13.6 min;
1H NMR (400 MHz, CDCl3): d = 7.65 (d, J = 7.2 Hz, 2H),
7.64–7.50 (m, 1H), 7.44–7.33 (m, 7H), 7.26–7.24 (m, 3H),
6.70–6.63 (m, 2H) ppm; 13C NMR (100 MHz, CDCl3): d =
166.3, 163.8, 116.4, 134.5, 134.3, 134.2, 137.8, 133.5,
132.0, 131.1, 129.3, 128.7, 128.5, 128.4, 126.9, 155.9,
155.7, 59.2 ppm; ESI–MS: m/z = 410.0 ([M?Na]?); IR
(KBr): m = 3308, 3064, 1660, 1570, 1435, 1010, 960, 775,
N-[(4-Chlorophenylthio)(p-tolyl)methyl]benzamide
(4h, C21H18ClNOS)
White solid; m.p.: 198–199 °C; 80 % ee determined by
HPLC analysis (chiralpak OD-H, hexane/i-PrOH = 90:10,
1.0 cm3/min, 228 nm), tminor = 8.5 min, tmajor = 11.9 min;
1H NMR (400 MHz, CDCl3): d = 7.65 (d, J = 6.8 Hz, 2H),
7.64–7.50 (m, 1H), 7.47–7.36 (m, 6H), 7.26–7.17 (m, 4H),
6.73–6.66 (m, 2H), 2.35 (s, 1H) ppm; 13C NMR (100 MHz,
CDCl3): d = 166.2, 138.5, 135.3, 134.1, 133.6, 131.9,
131.6, 129.5, 129.2, 128.8, 128.7, 126.5, 126.0, 59.6,
21.3 ppm; ESI–MS: m/z = 390.1 ([M?Na]?); IR (KBr): m
= 3311, 3054, 1676, 1580, 1500, 1030, 806, 730, 691,
701 cm-1
.
N-[(4-Chlorophenylthio)(4-bromophenyl)methyl]benza-
mide (4e, C20H15BrClNOS)
463 cm-1
.
White solid; m.p.: 202–205 °C; 90 % ee determined by
HPLC analysis (chiralpak OD-H, hexane/i-PrOH = 90:10,
1.0 cm3/min, 228 nm), tminor = 11.1 min, tmajor = 14.2 min;
1H NMR (400 MHz, CDCl3): d = 7.65 (d, J = 7.6 Hz, 2H),
7.54–7.49 (m, 3H), 7.44–7.36 (m, 6H), 7.25–7.21 (m, 2H),
6.68–6.61 (m, 2H) ppm; 13C NMR (100 MHz, CDCl3): d =
166.3, 134.4, 134.6, 133.9, 133.4, 132.0, 130.9, 129.4,
128.8, 128.3, 126.9, 122.6, 59.3 ppm; ESI–MS: m/z =
453.9 ([M?Na]?); IR (KBr): m = 3303, 3055, 1665, 1578,
N-[(4-Bromophenylthio)(phenyl)methyl]benzamide
(4i, C20H16BrNOS)
White solid; m.p.: 187–189 °C; 78 % ee determined by
HPLC analysis (chiralpak OD-H, hexane/i-PrOH = 90:10,
1.0 cm3/min, 228 nm), tminor = 9.5 min, tmajor = 15.0 min;
1H NMR (400 MHz, CDCl3): d = 7.66 (d, J = 6.8 Hz, 2H),
7.65–7.47 (m, 3H), 7.43–7.30 (m, 9H), 7.77–7.71 (m, 2H)
ppm; 13C NMR (CDCl3): d = 166.3, 138.3, 133.9, 132.6,
132.1, 132.0, 128.9, 128.9, 128.7, 128.6, 126.6, 122.2,
59.5 ppm; ESI–MS: m/z = 420.0 ([M?Na]?); IR (KBr): m
1473, 1067, 803, 732, 683, 671, 459 cm-1
.
123